Sulforaphane in Cutaneous Disorders and Skin Injury: Mechanisms, Evidence, and Clinical Perspectives
Nutrients · 30.04.2026 · 18 (9) · 1444
DOI: 10.3390/nu18091444 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.04.2026. Verfasst von Hua Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stanley Division of Developmental Neurovirology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Hauptthemen laut MEDLINE: Isothiocyanates, Sulfoxides, Skin Diseases, Skin. Die Arbeit nennt 268 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous disorders such as atopic dermatitis, psoriasis, acne vulgaris, and rosacea, together with UV-induced skin injury and photoaging, are highly prevalent conditions that involve varying contributions from dysregulated immune responses, cutaneous inflammation, oxidative stress, barrier dysfunction, microbiome alteration, and exogenous injury. However, these conditions are biologically heterogeneous and should not be regarded as a single mechanistic class. Sulforaphane, a naturally occurring isothiocyanate found primarily in broccoli and other cruciferous vegetables, has attracted interest in dermatology because of its antioxidant, cytoprotective, and context-dependent anti-inflammatory properties. Sulforaphane exerts its biological effects by modulating key signaling pathways, particularly the Keap1/Nrf2 pathway and, in some settings, NF-κB-related signaling, thereby reducing oxidative stress and inflammation, regulating immune responses, enhancing skin barrier function, and potentially influencing the cutaneous microbiome. Preclinical studies and limited human data suggest that sulforaphane may reduce erythema, edema, and other markers of cutaneous damage in selected settings. This comprehensive review explores the role of sulforaphane across heterogeneous cutaneous conditions, with emphasis on molecular mechanisms, disease-specific differences, current evidence, and discusses key translational constraints including formulation, delivery, lack of standardized dosing, and the limitations of cell culture and animal models for predicting human efficacy. Overall, sulforaphane should presently be regarded as a promising but still early-stage translational candidate in dermatology. Robust human efficacy data remain lacking for chronic inflammatory dermatoses such as psoriasis, atopic dermatitis, acne, and rosacea, whereas the strongest current human evidence relates to UV-associated skin outcomes and photoprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stanley Division of Developmental Neurovirology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Physiology, Pharmacology & Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- iMIND Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Institute of Medicine, University of Maine, Orono, ME 04469, USA.
ORCID-Profile: Hua Liu, Jed W Fahey
Zitieren
APA
Liu, H., Shi, C. Y., & Fahey, J. W. (2026). Sulforaphane in Cutaneous Disorders and Skin Injury: Mechanisms, Evidence, and Clinical Perspectives. Nutrients, 18(9), 1444. https://doi.org/10.3390/nu18091444
Vancouver
Liu H, Shi CY, Fahey JW. Sulforaphane in Cutaneous Disorders and Skin Injury: Mechanisms, Evidence, and Clinical Perspectives. Nutrients. 2026;18(9):1444. doi:10.3390/nu18091444
BibTeX
@article{Liu2026,
author = {Liu, Hua and Shi, Claire Y and Fahey, Jed W},
title = {Sulforaphane in Cutaneous Disorders and Skin Injury: Mechanisms, Evidence, and Clinical Perspectives},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {9},
pages = {1444},
doi = {10.3390/nu18091444}
}
EUVIMED